The cancer supportive care products global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Cancer Supportive Care Products Market, 2024The cancer supportive care products global market report 2024
Market Size –
The cancer supportive care products market size has grown steadily in recent years. It will grow from $20.58 billion in 2023 to $21.56 billion in 2024 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to growing cancer incidence, increased awareness and education, improved healthcare infrastructure, a growing geriatric population, increased awareness, and early detection.
The cancer supportive care products market size is expected to see steady growth in the next few years. It will grow to $26.1 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to the rising prevalence of cancer, growing patient-centric approaches, growing investment in cancer research, a rising focus on personalized medicine, and rising cancer survival rates. Major trends in the forecast period include technological advancements, advanced drug delivery systems, new drug formulations, personalized care, and the and the development of biodegradable products.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cancer-supportive-care-products-global-market-report
Scope Of Cancer Supportive Care Products Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Cancer Supportive Care Products Market Overview
Market Drivers –
The increasing cancer incidence is expected to propel the growth of the cancer supportive care products market going forward. As populations age, the risk of developing cancer increases due to cellular changes and prolonged exposure to risk factors. Additionally, factors such as smoking, poor diet, lack of physical activity, and excessive alcohol consumption contribute significantly to cancer risk. Cancer supportive care products are used to manage symptoms, improve quality of life, and support patients undergoing treatment, addressing the growing need due to the increasing incidence of cancer. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, there were projected to be 58,450 cases of oral cavity and pharynx cancer, reflecting a 7.2% increase from the 54,540 cases reported in 2023. Therefore, the increasing cancer incidence will drive the growth of the cancer supportive care products market.
Market Trends –
Major companies operating in the cancer supportive care products market are focusing on advancements in cancer therapies, such as a targeted radioligand therapy (RLT) platform, to enhance treatment efficacy, reduce side effects, and improve overall patient outcomes. A targeted radioligand therapy (RLT) platform uses radiolabeled molecules that specifically bind to cancer cell markers to deliver localized radiation and selectively destroy cancer cells while sparing healthy tissue. For instance, in May 2022, Novartis AG, a Switzerland-based pharmaceutical corporation, received US Food and Drug Administration (FDA) approval for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for treating adult patients with prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that has spread despite prior treatments. Pluvicto is the first FDA-approved targeted radioligand therapy (RLT) for eligible mCRPC patients, combining a targeting ligand with a therapeutic radioisotope. The FDA has also approved Locametz (gallium Ga 68 gozetotide injection), which is used in PET scans to detect PSMA-positive lesions, helping to locate cancer spread and determine eligibility for Pluvicto treatment.
The cancer supportive care products market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Granulocyte Colony Stimulating Factor
2) By Indication: Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies
Get an inside scoop of the cancer supportive care products market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18529&type=smp
Regional Insights –
North America was the largest region in the cancer supportive care products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies in the market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Limited, Baxter International Inc., Daiichi Sankyo Company Limited, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Kyowa Hakko Kirin Co. Ltd., QIAGEN N.V., Exelixis Inc., Fagron Group B.V., Tessa Therapeutics Pte Ltd., Mirati Therapeutics Inc., APR Applied Pharma Science Research S.A., Acacia Pharma Ltd., Arquer Diagnostics Ltd.
Table of Contents
1. Executive Summary
2. Cancer Supportive Care Products Market Characteristics
3. Cancer Supportive Care Products Market Trends And Strategies
4. Cancer Supportive Care Products Market – Macro Economic Scenario
5. Global Cancer Supportive Care Products Market Size and Growth
…
32. Global Cancer Supportive Care Products Market Competitive Benchmarking
33. Global Cancer Supportive Care Products Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cancer Supportive Care Products Market
35. Cancer Supportive Care Products Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
